(Q37855782)

English

Indomethacin/prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache

scientific article published on April 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Indomethacin/prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Lesley J Scott

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

Sheridan M Hoy

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

343-358

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

The International Classification of Headache Disorders: 2nd edition

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Migraine--current understanding and treatment

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Acute migraine therapy: recent evidence from randomized comparative trials

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

EFNS guideline on the treatment of tension-type headache - report of an EFNS task force

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

New drugs for migraine

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

A study of the effects of indometacin on liver mitochondria from rats, mice and humans

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in in vivo models of migraine.

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Prochlorperazine induces central antinociception mediated by the muscarinic system

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Treatment of elevated intracranial pressure with indomethacin: friend or foe?

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

A benefit-risk assessment of caffeine as an analgesic adjuvant.

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraine and cluster headache

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients.

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel gro

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Acute treatment of migraine headaches.

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Diagnosis and management of the primary headache disorders in the emergency department setting

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal

1 reference

https://api.crossref.org/works/10.2165%2F11206740-000000000-00000

21 January 2018

Caffeine as an analgesic adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/21425885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for controlled trials of drugs in tension-type headache: second edition.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21425885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro effect of indomethacin on polymorphonuclear leukocyte function in preterm infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/21425885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short- and long-term treatment with indometacin causes renal phospholipid alteration: a possible explanation for indomethacin nephrotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21425885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caffeine consumption, withdrawal and cerebral blood flow.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21425885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central mechanism of indomethacin analgesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21425885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caffeine induces central cholinergic analgesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21425885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater

1 reference

https://pubmed.ncbi.nlm.nih.gov/21425885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tension-type headache

1 reference

https://pubmed.ncbi.nlm.nih.gov/21425885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology of prochlorperazine in healthy young males

1 reference

https://pubmed.ncbi.nlm.nih.gov/21425885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of nimesulide and indometacin on COX-1 and COX-2: a comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21425885

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11206740-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37855782&oldid=2201019601"